VAUGHAN NELSON INVESTMENT MANAGEMENT, L.P. recently filed their 13F report for the fourth quarter of 2022, which ended on 2022-12-31.
The 13F report details which stocks were in a guru’s equity portfolio at the end of the quarter, though investors should note that these filings are limited in scope, containing only a snapshot of long positions in U.S.-listed stocks and American depository receipts as of the quarter’s end. They are not required to include international holdings, short positions or other types of investments. Still, even this limited filing can provide valuable information.
Vaughan Nelson Investment Management is an investment management company based out of Houston, Texas. The company was founded in 1970 and is currently headed by CEO and CIO Christopher D. Wallis. Vaughan Nelson Investment Management operates as a subsidiary of Natixis Global Asset Management with a minor portion of company ownership being held by key executives. The company currently has 38 employees with 15 of them being investment professionals. Vaughan Nelson Investment Management conducts its research in house and utilizes a fundamental analysis and a bottom up investment approach. The company invests in the public equity and fixed income markets of the U.S. across all market caps, focusing on the growth and value stocks of companies. Vaughan Nelson Investment Management invests most heavily in the finance sector, which alone makes up almost a quarter of its total allocated assets, and the company also invests in the information technology, health care, consumer discretionary, industrials, and materials sectors, among others to a lesser degree, in order of decreasing allocation. The company currently has $10.7 billion in assets under management spread across 520 accounts, all of which are discretionary except for 21, making up approximately $800 milion of its held assets. Both its total number of accounts held and assets under management have been increasing in recent years with its total held accounts growing from under 300 five years ago and its total assets under management growing from $6.7 billion to its current amount. Vaughan Nelson Investment Management mainly caters to high net worth individuals, which alone makes up over a third of its client base, although it also caters to corporations, individuals, investment advisors, state or municipal entities, pooled investment vehicles, charities, and others, in order of decreasing clientele. The company currently offers its Select, Value Opportunity, Small Cap Value, Core Fixed Income and Intermediate Fixed income, Customized DUratino, Limited Maturity, and Tax-Free strategies.
As of the latest 13F report, the guru’s equity portfolio contained 220 stocks valued at a total of $7.72Bil. The top holdings were
According to GuruFocus data, these were VAUGHAN NELSON INVESTMENT MANAGEMENT, L.P.’s top five trades of the quarter.
Berkshire Hathaway Inc
VAUGHAN NELSON INVESTMENT MANAGEMENT, L.P. reduced their investment in NYSE:BRK.B by 437,023 shares. The trade had a 1.61% impact on the equity portfolio. During the quarter, the stock traded for an average price of $284.56.
On 01/31/2023, Berkshire Hathaway Inc traded for a price of $306.82 per share and a market cap of $676.55Bil. The stock has returned -1.98% over the past year.
GuruFocus gives the company a financial strength rating of 5 out of 10 and a profitability rating of 8 out of 10.
In terms of valuation, Berkshire Hathaway Inc has a price-book ratio of 1.49, a EV-to-Ebitda ratio of 68.41 and a price-sales ratio of 2.72.
The price-to-GF Value ratio is 1.14, earning the stock a GF Value rank of 3.
Nutrien Ltd
The guru sold out of their 1,382,256-share investment in NYSE:NTR. Previously, the stock had a 1.49% weight in the equity portfolio. Shares traded for an average price of $86.02 during the quarter.
On 01/31/2023, Nutrien Ltd traded for a price of $81.605 per share and a market cap of $42.72Bil. The stock has returned 18.67% over the past year.
GuruFocus gives the company a financial strength rating of 6 out of 10 and a profitability rating of 9 out of 10.
In terms of valuation, Nutrien Ltd has a price-earnings ratio of 5.81, a price-book ratio of 1.64, a price-earnings-to-growth (PEG) ratio of 0.21, a EV-to-Ebitda ratio of 4.26 and a price-sales ratio of 1.24.
The price-to-GF Value ratio is 0.89, earning the stock a GF Value rank of 9.
Vertex Pharmaceuticals Inc
VAUGHAN NELSON INVESTMENT MANAGEMENT, L.P. reduced their investment in NAS:VRTX by 357,332 shares. The trade had a 1.36% impact on the equity portfolio. During the quarter, the stock traded for an average price of $287.72.
On 01/31/2023, Vertex Pharmaceuticals Inc traded for a price of $323.31 per share and a market cap of $82.99Bil. The stock has returned 32.66% over the past year.
GuruFocus gives the company a financial strength rating of 9 out of 10 and a profitability rating of 7 out of 10.
In terms of valuation, Vertex Pharmaceuticals Inc has a price-earnings ratio of 25.50, a price-book ratio of 6.37, a price-earnings-to-growth (PEG) ratio of 0.20, a EV-to-Ebitda ratio of 17.30 and a price-sales ratio of 9.60.
The price-to-GF Value ratio is 1.01, earning the stock a GF Value rank of 5.
Sherwin-Williams Co
During the quarter, VAUGHAN NELSON INVESTMENT MANAGEMENT, L.P. bought 427,561 shares of NYSE:SHW for a total holding of 859,123. The trade had a 1.27% impact on the equity portfolio. During the quarter, the stock traded for an average price of $236.9.
On 01/31/2023, Sherwin-Williams Co traded for a price of $233.515 per share and a market cap of $60.51Bil. The stock has returned -17.77% over the past year.
GuruFocus gives the company a financial strength rating of 4 out of 10 and a profitability rating of 9 out of 10.
In terms of valuation, Sherwin-Williams Co has a price-earnings ratio of 37.42, a price-book ratio of 19.51, a price-earnings-to-growth (PEG) ratio of 2.81, a EV-to-Ebitda ratio of 20.76 and a price-sales ratio of 2.75.
The price-to-GF Value ratio is 0.77, earning the stock a GF Value rank of 10.
Johnson & Johnson
VAUGHAN NELSON INVESTMENT MANAGEMENT, L.P. reduced their investment in NYSE:JNJ by 526,036 shares. The trade had a 1.26% impact on the equity portfolio. During the quarter, the stock traded for an average price of $169.22.
On 01/31/2023, Johnson & Johnson traded for a price of $161.39 per share and a market cap of $421.95Bil. The stock has returned -3.60% over the past year.
GuruFocus gives the company a financial strength rating of 7 out of 10 and a profitability rating of 9 out of 10.
In terms of valuation, Johnson & Johnson has a price-earnings ratio of 23.95, a price-book ratio of 5.66, a price-earnings-to-growth (PEG) ratio of 6.14, a EV-to-Ebitda ratio of 14.91 and a price-sales ratio of 4.52.
The price-to-GF Value ratio is 0.91, earning the stock a GF Value rank of 6.
Please note, the numbers and facts quoted are as of the writing of this article and may not factor in the latest trading data or company announcements.
When GuruFocus covers insider information, we only track open market or the private purchase and sale of common stock with the transaction code of P or S. Therefore, all the transactions mentioned in this article are only the ones with transaction code of P or S.
Want to provide feedback on this article? Have questions or concerns? Get in touch with us here, or email us at [email protected]!
This article is general in nature and does not represent the opinions of GuruFocus or any of its affiliates. This article is not intended to be financial advice, nor does it constitute investment advice or recommendations. It was written without regard to your individual situation or financial goals. We aim to bring you fundamental, data-driven analysis, The information on this site is in no way guaranteed for completeness, accuracy or in any other way.
